These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fusidic acid as a potential antistaphylococcal agent. Nicholson J, Chew T, Smith S. N Z Med J; 1999 Jul 09; 112(1091):261-2. PubMed ID: 10448991 [No Abstract] [Full Text] [Related]
8. Methicillin resistance in Staphylococcus aureus with particular reference to Victorian strains. Harvey K, Pavillard R. Med J Aust; 1982 May 29; 1(11):465-7. PubMed ID: 7048040 [Abstract] [Full Text] [Related]
9. Methicillin- and gentamicin-resistant Staphylococcus aureus: susceptibility to fosfomycin, cefamandole, N-formimidoyl-thienamycin, clindamycin, fusidic acid and vancomycin. Graninger W, Leitha T, Breyer S, Francesconi M, Lenz K, Georgopoulos A. Drugs Exp Clin Res; 1985 May 29; 11(1):23-7. PubMed ID: 3869801 [Abstract] [Full Text] [Related]
10. Emergence of resistance to cephalothin and gentamicin during combination therapy for methicillin-resistant Staphylococcus aureus endocarditis in rabbits. Chambers HF, Miller MH. J Infect Dis; 1987 Mar 29; 155(3):581-5. PubMed ID: 3643249 [No Abstract] [Full Text] [Related]
11. Penicillinase-resistant penicillin/gentamicin synergism. Effect in patients with Staphylococcus aureus bacteremia. Licht JH. Arch Intern Med; 1979 Oct 29; 139(10):1094-8. PubMed ID: 258599 [Abstract] [Full Text] [Related]
12. The Burns Unit in Copenhagen. 10. Antibiotic sensitivity of Staphylococcus aureus isolated from burns. Thomsen M. Acta Pathol Microbiol Scand B Microbiol Immunol; 1971 Oct 29; 79(3):314-24. PubMed ID: 5283058 [No Abstract] [Full Text] [Related]